Study S000931

Randomized, Controlled Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05892432
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 50
Start: 2024-01-11
Primary completion: 2025-11-04
Lead sponsor: University of Colorado, Denver
Conditions: Alcohol Use Disorder
Interventions: DRUG:Semaglutide 3 MG [Rybelsus]; DRUG:Semaglutide 7 MG [Rybelsus]; DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: NIH:R21AA031146

Registered primary outcomes

Change in Cue Craving Visual Analog Score [7 weeks - change between screening and Week 6 visit]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.